Targeting ALDOB: A Protein Implicated in Many Diseases (G229)

Target Name: ALDOB

NCBI ID: G229

ALDOB

Targeting ALDOB: A Protein Implicated in Many Diseases

ALDOB (ALDOB_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and kidneys. It is a member of the ALDOB family, which includes proteins that are involved in a variety of cellular processes, including metabolism, stress response, and inflammation.

Recent studies have identified ALDOB as a potential drug target or biomarker for a variety of diseases, including neurodegenerative disorders, cardiovascular disease, and immune system dysfunction. This is because ALDOB is involved in the production of several proteins that are associated with the development and progression of these diseases.

For example, research has shown that ALDOB is involved in the production of amyloid, a protein that is known to contribute to the development of Alzheimer's disease. Amyloid is a common protein that is found in the brain, and it is believed to play a role in the destruction of nerve cells in the brain, leading to the symptoms of Alzheimer's disease.

In addition to its role in the production of amyloid, ALDOB has also been shown to be involved in the regulation of the immune system. This is important because an imbalance in the immune system has been implicated in the development of many diseases, including neurodegenerative disorders.

One potential way to target ALDOB as a drug or biomarker is through the use of small molecules or antibodies that can modulate its activity. This could involve using drugs that interfere with the production of amyloid, or using antibodies that specifically bind to and target ALDOB.

Another approach to targeting ALDOB is through the use of genetic tools, such as CRISPR/Cas9 genome editing technology. This allows researchers to make changes to the DNA of cells or organisms in order to introduce new genes or to modify existing ones. By using this technology, researchers can create mice or other animals that have altered levels of ALDOB or that are unable to produce amyloid.

Once these changes have been made, researchers can use them to study the effects of ALDOB on various physiological processes, including metabolism, stress response, and inflammation. This can help to identify new potential drug targets or biomarkers for ALDOB and related diseases.

Overall, ALDOB is a protein that is involved in a variety of cellular processes and has been implicated in the development and progression of many diseases. As a result, it is a promising target for drug development or biomarker research. Further studies are needed to fully understand its role and potential as a drug or biomarker.

Protein Name: Aldolase, Fructose-bisphosphate B

The "ALDOB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ALDOB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets